Gilead’s antiviral drug remdesivir flops in first trial

0
76
gilead’s-antiviral-drug-remdesivir-flops-in-first-trial

By Economic Times – Gilead’s antiviral drug remdesivir flops in first trial HealthcareStock Analysis, IPO, Mutual Funds, Bonds & MoreThe Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report said.Reuters|Last Updated: Apr 23, 2020, 10.31 PM ISTThe Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report said.Gilead Sciences Inc’s experimental coronavirus drug failed its first randomised clinical trial, the Financial Times reported on Thursday, citing draft documents published accidentally by the World Health Organization.

The Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report said.
Commenting feature is disabled in your country/region. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

For more details, please visit http://gestyy.com/w9MpZV

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.